Why the study?
Does plasma from patients with Cardiorenal Syndrome Type 1 induce apoptosis and inflammation in human tubular epithelial cells compared to plasma from HF patients and controls?
Does plasma from patients with Cardiorenal Syndrome Type 1 induce apoptosis and inflammation in human tubular epithelial cells compared to plasma from HF patients and controls?
Plasma from patients with Cardiorenal Syndrome Type 1 directly induces apoptosis and upregulates proinflammatory mediators in renal tubular epithelial cells in vitro, suggesting a circulating factor mediates renal injury in acute heart failure.
CRS1 plasma may drive tubular injury via circulating factors; hypothesis-generating for cardiorenal mechanisms, requiring in vivo confirmation before clinical relevance.
BACKGROUND: The pathophysiology of Cardiorenal Syndrome Type 1 (CRS1) is widely studied, although the mechanisms by which renal tubular epithelial cells (TECs) cease to proliferate and embark upon terminal differentiation, following the initial insult of heart failure (HF), remain a key target. This study seeks to provide insight into the pathophysiological pathways in CRS1; we evaluated in vitro the effects of CRS1 plasma on TECs. METHODS: We enrolled 40 acute HF patients and 15 controls (CTR) without HF or acute kidney injury (AKI). Ten out of 40 HF patients exhibited AKI at the time of admission for HF or developed AKI during hospitalization and were classified as CRS1. In vitro, cell viability, DNA fragmentation and caspase-3 levels were investigated in TECs incubated with HF, CRS1, and CTR plasma. We assessed inflammatory cytokines and NGAL expression at the gene and protein levels. RESULTS: We observed a marked pro-apoptotic activity and a significantly increased in vitro level of apoptosis in TECs incubated with plasma from CRS1 patients compared to HF and CTR (p < 0.01). In the CRS1 group, the mRNA expression of IL-6, IL-18 and NGAL resulted significantly higher in TECs incubated with CRS1 plasma compared with those incubated with plasma from HF and CTR (p < 0.01). IL-6, IL-18, NGAL, and RANTES levels were significantly higher in TECs supernatant incubated with CRS1 plasma compared with HF patients and CTR plasma (p < 0.01). CONCLUSION: In vitro exposure to plasma from CRS1 patients altered the expression profile of TECs characterized by increases in proinflammatory mediators, release of tubular damage markers, and apoptosis.
No takes yet. Share an insight, caveat, or question.
Virzì et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: